BACKGROUND
The understanding of the pathogenesis of periodontitis makes various progresses in the last decades. Today it is well known that the synthesis of high levels of pro-inflammatory mediators from gingival tissue in response to periodontopathogens results in destruction of soft and hard periodontal tissues and clinical expression of periodontal disease (9, 10). There is enough evidence that PGE2 and IL-1β β β β β are important mediators in the periodontal inflammation and bone destruction and are involved in tissue response regulation. It is well known that IL-1β β β β β stimulate bone loss and have inhibitory effect to bone forming (4, 6) . Prostaglandin E2 (PGE2) is one of the key mediators in the periodontal inflammation by stimulating the suppression of lymphocyte production, decreasing the collagen synthesis by fibroblasts and influencing osteoclastic bone resorption (11, 12, 15) .
There is great number of evidence that PGE2 assist regulation of IL-1β β β β β production and is involved in the inflammatory reaction and tissue destruction. It is accepted that PGE2 and IL-1β β β β β are key cytokines of inflammation and clinical attachment loss and bone loss. The rates of proinflammatory cytokines PGE2 and IL-1β β β β β in crevicular fluid and gingival tissue in patients with chronic periodontitis are increasing proportionally to severity of periodontal disease (6, 8, 10, 15) . The examination of these cytokines may enhance the understanding of pathogenesis of periodontitis and their assessment in the treatment process may result in better control of patient's disease.
The modification of destructive host response against periodontopathogens by inhibition of pro-inflammatory cytokines has a potential therapeutic means in the treatment of periodontitis. Reduction in the levels of pro-inflammatory mediators by using NSAIDs may reduce host modulation bone resorption in chronic periodontitis (12, 13, 14) . Numerous studies exhibit better treatment effect with additional use of non-steroidal anti-inflammatory drug (NSAID) in non-surgical periodontal therapy (3, 14, 15) .
NSAIDs include a suppressing effect of prostaglandin synthesis via COX-1 and COX-2 and may act as inhibitor of gingival inflammation and bone destruction (5, 11, 12, 14) . Detection of elevated levels of PGE2 and IL-1β β β β β in gingival tissue may be recognized as indicator for activity of periodontitis and may provide the evaluation of recurrence and progression of disease. Reducing the production of PGE2 and IL-1β β β β β after treatment may be indicator for successful periodontal therapy. Higher levels of this cytokines in crevicular fluid and gingival tissue of periodontal patients in supporting periodontal treatment can be capable predictor of further destruction.
Aim of the study:
To evaluate the effectiveness of additional therapy with NSAID (Aulin ® ) in non-surgical therapy of chronic periodontitis by measurement of PGE2 and IL-1β β β β β gene expression levels in patients gingival tissue.
MATERIALS AND METODS
It were measured PGE2 and IL-1β β β β β gene expression levels in gingival tissue of chronic periodontitis patients before and after non-surgical periodontal therapy (control group), gene expression levels of PGE2 and IL-1β β β β β in gingival tissue of chronic periodontitis patients before and after conventional mechanical therapy plus additional therapy with COX-2 inhibitor Aulin ® (test group). The comparative analysis of PGE2 and IL-1β β β β β gene expression levels in gingival tissue of two patient groups: suffering from chronic periodontitis receiving conventional mechanical therapy alone and those receiving mechanical therapy and additional host modulation therapy with NSAID (Aulin ® ) was made.
Patients selection -
A. Test group -20 chronic periodontitis patients receive non-surgical periodontal therapy with adjunctive systemic administration of NSAID (Aulin ® ) -for 14 day, 100 mg per day.
B. Control group -10 chronic periodontitis patients receive non-surgical periodontal therapy alone.
2.Tag Man Real Time -
Quantitative TaqMan Real Time-PCR (Polimerase Chain reaction in Real time) was used for gene expression analyses of amount of inflammation mediators IL-1β and PGE2 in gingival tissue of patients with periodontitis.
This method is based on PCR technology. The difference is that here we use TaqManProbe which is fluorescently labeled and allow detection in Real time. The 5'-3' exonuclease activity of the Taq polymerase enzyme is cutting the Reporter Dye and fluorescence rise with every cycle. This allows detection in real time (2, 7) .
TaqMan Real Time-PCR can be used for qualitative, quantitative and comparative studies.
In this study the examined material was gingival tissue, harvested from interproximal area in distal dentition.
3.Analysis of PGE2 and IL-1β β β β β gene expression levels in gingival tissue was performed by:
Gene Expression Analyses of IL-1β and PGE2 in gingival tissues · Isolation of the total RNA from gingival tissue was made using RiboPure isolation kit (Roboscreen Germany) · Followed by reverse transcription of the total RNA · Amplification with specific TaqMan Gene Expression Assays for IL-1β and PGE2 (Applied Biosystems) on ABI 7500 and RQ -software (1, 2, 7) .
The statistic method used for data procession was Spearman analysis.
RESULTS AND DISCUSSION
The following two diagrams (diagram 1 and diagram 2) represent the results of gene expression levels of Il-1â in gingival tissue of chronic periodontitis patients from two groups.
The following two diagrams (diagram 3 and diagram 4) represent the results of gene expression levels of PGE2 in gingival tissue of chronic periodontitis patients from two groups.
The PGE2 and IL-1β (ddCt) gene expression level deviations between two groups of patients were compared. In 42% of the patients treated with Aulin ® an inhibition of the IL-1β was registered and in 37% of these patients an inhibition of the PGE2 was registered. It can be noticed that the inhibition of PGE2 gene expression is higher then the suppression of IL-1β gene expression. This occurrence is logical concerning the fact that PGE2 influence the IL-1β expression in a previous stage of the inflammatory process (10).
In patients receiving conventional periodontal treatment without adjunctive Aulin ® the PGE2 and IL-1β gene expression depict lower level of inhibition (table 1) .
Negative values of ddCt in both groups reflect lower level of inhibition of gene expression (diagrams 1-4). Statistically significant differences were found between test and control group in the inhibition of PGE2 and IL-1β gene expression ( The received correlative coefficient with Spearman analysis is respectively t = -0,72 (p<0,05) for IL-1β, and t = 0,82 (p< 0,05) for PGE2. The comparative analysis of average values demonstrates slight difference between both of groups. However the alterations in PGE2 and IL-1β gene expression levels are higher in patients additionally treated with Aulin ® .
The descriptive statistic by Sigma Stat software shows statistically significant differences in PGE2 and IL-1β gene expression levels with higher inhibition in the experimental group supporting the hypothesis of this study.
CONCLUSION
Results of this study confirm the effectiveness of non-surgical therapy in moderate and severe periodontitis.
The significant difference in PGE2 and IL-1β gene expression levels betweenboth groups confirm the advantage of the experimental therapy with additional administration of non-steroidal anti-inflammatory agent (Aulin ® ). Additional use of non-steroidal anti-inflammatory agent results in higher effectiveness of initial treatment of chronic perodontitis.
The laboratory examination demonstrated inhibition of gene expression levels of important pro-inflammatory cytokines like PGE2 and IL-1β, and confirms the approach to modification of the host response in the treatment of chronic periodontitis.
The recorded variations in PGE2 and IL-1β gene expression levels in this study suggested the rationale for additional investigations upon various factors, influencing the production of different cytokines in gingival tissues.
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